Oct 2012: dabl and Quintiles announce a strategic alliance.
dabl and Quintiles (the world's leading provider of biopharmaceutical services), announce a strategic alliance. Through the alliance, Quintiles' customers worldwide will have access to dabl's online blood pressure monitoring solutions to enhance the safety and efficacy of global clinical trials. Click here for the full announcement.

May 2012: dabl joins the Cardiac Safety Research Consortium
Collaboration to focus on blood pressure monitoring to assess cardiac safety in drug trials.

Aug 2011: dabl centralized blood pressure system selected for Phase III trial in 19 countries
dabl Ltd has been selected as a preferred provider for centralized 24 hour ambulatory and home blood pressure monitoring by a major European pharmaceutical company for a Phase III trial involving 260 sites around the globe.

Feb 2011: dabl Ltd to exhibit at the 23rd DIA Annual Euromeeting in Geneva
dabl Ltd is pleased to announce that we will exhibit at the upcoming 23rd DIA Annual EuroMeeting (28-30 March 2010 in Geneva, Switzerland). Visit us at booth no. 1186.

June 2010: Independent study reveals dabl system leads the way in accurate cardiovascular diagnosis
dabl’s computerised system for diagnosing 24 hour blood pressure is more accurate and consistent than a leading group of international hypertension experts, an independent study has revealed.

Register for our newsletter and receive a whitepaper on "Using 24-hr ABPM in Clinical Trials"